NGNE
Price
$20.99
Change
-$0.37 (-1.73%)
Updated
Nov 19 closing price
Capitalization
325.44M
Intraday BUY SELL Signals
TNGX
Price
$8.29
Change
+$0.28 (+3.50%)
Updated
Nov 19 closing price
Capitalization
1.11B
130 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NGNE vs TNGX

Header iconNGNE vs TNGX Comparison
Open Charts NGNE vs TNGXBanner chart's image
Neurogene
Price$20.99
Change-$0.37 (-1.73%)
Volume$130.52K
Capitalization325.44M
Tango Therapeutics
Price$8.29
Change+$0.28 (+3.50%)
Volume$5.34M
Capitalization1.11B
NGNE vs TNGX Comparison Chart in %
NGNE
Daily Signal:
Gain/Loss:
TNGX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NGNE vs. TNGX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGNE is a Hold and TNGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (NGNE: $21.01 vs. TNGX: $8.28)
Brand notoriety: NGNE and TNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NGNE: 55% vs. TNGX: 100%
Market capitalization -- NGNE: $325.44M vs. TNGX: $1.11B
NGNE [@Biotechnology] is valued at $325.44M. TNGX’s [@Biotechnology] market capitalization is $1.11B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NGNE’s FA Score shows that 0 FA rating(s) are green whileTNGX’s FA Score has 0 green FA rating(s).

  • NGNE’s FA Score: 0 green, 5 red.
  • TNGX’s FA Score: 0 green, 5 red.
According to our system of comparison, TNGX is a better buy in the long-term than NGNE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NGNE’s TA Score shows that 3 TA indicator(s) are bullish while TNGX’s TA Score has 5 bullish TA indicator(s).

  • NGNE’s TA Score: 3 bullish, 6 bearish.
  • TNGX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TNGX is a better buy in the short-term than NGNE.

Price Growth

NGNE (@Biotechnology) experienced а -32.40% price change this week, while TNGX (@Biotechnology) price change was +7.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

TNGX is expected to report earnings on Mar 30, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNGX($1.11B) has a higher market cap than NGNE($325M). TNGX YTD gains are higher at: 167.961 vs. NGNE (-8.093). NGNE has higher annual earnings (EBITDA): -81.25M vs. TNGX (-154.8M). NGNE has more cash in the bank: 275M vs. TNGX (181M). NGNE has less debt than TNGX: NGNE (12.9M) vs TNGX (35M). TNGX has higher revenues than NGNE: TNGX (24.3M) vs NGNE (0).
NGNETNGXNGNE / TNGX
Capitalization325M1.11B29%
EBITDA-81.25M-154.8M52%
Gain YTD-8.093167.961-5%
P/E RatioN/AN/A-
Revenue024.3M-
Total Cash275M181M152%
Total Debt12.9M35M37%
FUNDAMENTALS RATINGS
NGNE: Fundamental Ratings
NGNE
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NGNETNGX
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 28 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
NGNE
Daily Signal:
Gain/Loss:
TNGX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IBNCX25.060.04
+0.16%
Macquarie Balanced Fund Class C
BRLVX26.740.04
+0.15%
American Beacon Man Lg Cp Value R5
SNWAX66.24N/A
N/A
Easterly Snow Small Cap Value A
NRLCX51.48N/A
N/A
Neuberger Berman Large Cap Value R6
MXETX13.21N/A
N/A
Empower Core Strategies US Eq Inv

NGNE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NGNE has been loosely correlated with BRNS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NGNE jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGNE
1D Price
Change %
NGNE100%
-1.64%
BRNS - NGNE
51%
Loosely correlated
-0.32%
RNAZ - NGNE
48%
Loosely correlated
-1.44%
ZNTL - NGNE
48%
Loosely correlated
-2.21%
OCUL - NGNE
45%
Loosely correlated
+2.81%
STOK - NGNE
43%
Loosely correlated
-1.49%
More

TNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNGX has been loosely correlated with CLDX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TNGX jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNGX
1D Price
Change %
TNGX100%
+3.50%
CLDX - TNGX
43%
Loosely correlated
-2.58%
XNCR - TNGX
42%
Loosely correlated
-1.62%
FDMT - TNGX
42%
Loosely correlated
+7.14%
AXON - TNGX
41%
Loosely correlated
-0.50%
NGNE - TNGX
40%
Loosely correlated
-1.64%
More